"Survival Rate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods.
| Descriptor ID |
D015996
|
| MeSH Number(s) |
E05.318.308.985.550.900 N01.224.935.698.826 N06.850.505.400.975.550.900 N06.850.520.308.985.550.900
|
| Concept/Terms |
Survival Rate- Survival Rate
- Rate, Survival
- Rates, Survival
- Survival Rates
Mean Survival Time- Mean Survival Time
- Mean Survival Times
- Survival Time, Mean
- Survival Times, Mean
- Time, Mean Survival
- Times, Mean Survival
Cumulative Survival Rate- Cumulative Survival Rate
- Cumulative Survival Rates
- Rate, Cumulative Survival
- Rates, Cumulative Survival
- Survival Rate, Cumulative
- Survival Rates, Cumulative
|
Below are MeSH descriptors whose meaning is more general than "Survival Rate".
Below are MeSH descriptors whose meaning is more specific than "Survival Rate".
This graph shows the total number of publications written about "Survival Rate" by people in this website by year, and whether "Survival Rate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 23 | 23 |
| 1996 | 0 | 20 | 20 |
| 1997 | 0 | 12 | 12 |
| 1998 | 0 | 23 | 23 |
| 1999 | 0 | 18 | 18 |
| 2000 | 0 | 12 | 12 |
| 2001 | 0 | 24 | 24 |
| 2002 | 0 | 18 | 18 |
| 2003 | 0 | 28 | 28 |
| 2004 | 0 | 28 | 28 |
| 2005 | 0 | 39 | 39 |
| 2006 | 0 | 44 | 44 |
| 2007 | 0 | 41 | 41 |
| 2008 | 0 | 54 | 54 |
| 2009 | 0 | 41 | 41 |
| 2010 | 1 | 52 | 53 |
| 2011 | 0 | 74 | 74 |
| 2012 | 0 | 60 | 60 |
| 2013 | 1 | 66 | 67 |
| 2014 | 2 | 75 | 77 |
| 2015 | 0 | 71 | 71 |
| 2016 | 1 | 85 | 86 |
| 2017 | 1 | 95 | 96 |
| 2018 | 1 | 95 | 96 |
| 2019 | 2 | 85 | 87 |
| 2020 | 0 | 81 | 81 |
| 2021 | 0 | 39 | 39 |
| 2022 | 0 | 12 | 12 |
| 2023 | 0 | 13 | 13 |
| 2024 | 0 | 39 | 39 |
| 2025 | 0 | 4 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Survival Rate" by people in Profiles.
-
Clinical and genetic markers of vascular toxicity in glioblastoma patients: Insights from NRG Oncology RTOG-0825. Neuro Oncol. 2025 Mar 07; 27(3):767-778.
-
Polygenic Score for Clinicopathologic Features and Survival Outcomes in Papillary Thyroid Carcinoma. JAMA Otolaryngol Head Neck Surg. 2025 Feb 01; 151(2):113-120.
-
Incidence and Survival of Children and Adolescents With Wilms Tumor, United States, 2001-2020. Cancer Med. 2025 Feb; 14(3):e70598.
-
The Association Between Thyroid Differentiation Score and Survival Outcomes in Papillary Thyroid Carcinoma. J Clin Endocrinol Metab. 2025 Jan 21; 110(2):356-363.
-
Associations of KRAS Point Mutations with Survival of Patients Who Underwent Curative-Intent Resection of Colorectal Liver Metastases. Ann Surg Oncol. 2025 Apr; 32(4):2425-2434.
-
Daratumumab plus lenalidomide/dexamethasone in untreated multiple myeloma: analysis of key subgroups of the MAIA study. Leukemia. 2025 Mar; 39(3):710-719.
-
Longitudinal multimodal profiling of IDH-wildtype glioblastoma reveals the molecular evolution and cellular phenotypes underlying prognostically different treatment responses. Neuro Oncol. 2025 Jan 12; 27(1):89-105.
-
Concomitant antihistamine administration is associated with improved survival outcomes in patients with locally advanced or metastatic urothelial carcinoma treated with atezolizumab. Analysis of individual participant data from IMvigor210 and IMvigor211. Urol Oncol. 2025 Mar; 43(3):188.e9-188.e17.
-
Surgical Margins and Oncologic Outcomes Following Wedge Resection of Pulmonary Metastases in Pediatric and Young Adult Patients with Sarcoma. Ann Surg Oncol. 2025 Apr; 32(4):2883-2890.
-
ASO Visual Abstract: Real-World Implications of the SOUND Trial. Ann Surg Oncol. 2025 Jan; 32(1):121-122.